 |
But holes in evidence mean risk-benefit balance remains unclear in many people Related items from OnMedica Statins associated with 46% increased diabetes risk Statins may reduce effectiveness of flu jab Statins controversy prompted patients to stop treatment Major review clears statins Higher dose statins could prolong lives of CVD patients |
Tuesday, 15 November 2016
US expert group updates statins recommendations
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment